News >

Future of mCRC Lies in Biomarker-Directed Therapies

Kristi Rosa
Published: Wednesday, Jun 12, 2019

Christopher Lieu, MD

Christopher Lieu, MD

Some of the most exciting research being conducted in metastatic colorectal cancer (mCRC) has been in the form of biomarker-directed therapy and immunotherapy, said Christopher Lieu, MD. Although these advances have been made in only a small percentage of the overall population, these personalized approaches have led to significant improvements in survival.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Archived Version of a Live Webcast: Virtual Current Trends™: European Perspectives on the Advancing Role of CAR T-Cell Therapy in Hematologic MalignanciesJun 29, 20192.0
Community Practice Connections™: Practical Application of Sequencing for EGFR-Mutant Lung Cancers: A Focus on Recent Evidence and Key Next Steps in TrialsJun 29, 20192.5
Publication Bottom Border
Border Publication